Synergistic Mixtures of Anthranilamide Invertebrate Pest Control Agents
First Claim
1. A mixture comprising:
- (a) a compound of Formula 1, 3-bromo-N-[4-chloro-2-methyl-6-[(methylamino)carbonyl]phenyl]-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide, an N-oxide, or a salt thereof, and a component (b) wherein the component (b) is at least one invertebrate pest control agent selected from the group consisting of (b1) neonicotinoids;
(b2) cholinesterase inhibitors;
(b3) sodium channel modulators;
(b4) chitin synthesis inhibitors;
(b5) ecdysone agonists;
(b6) lipid biosynthesis inhibitors;
(b7) macrocyclic lactones;
(b8) GABA-regulated chloride channel blockers;
(b9) juvenile hormone mimics;
(b10) ryanodine receptor ligands;
(b11) octopamine receptor ligands;
(b12) mitochondrial electron transport inhibitors;
(b13) nereistoxin analogs;
(b14) pyridalyl;
(b15) flonicamid;
(b16) pymetrozine;
(b17) dieldrin;
(b18) metaflumizone;
(b19) biological agents; and
salts of compounds of (b1) through (b18).
2 Assignments
0 Petitions
Accused Products
Abstract
Disclosed are mixtures and compositions for controlling invertebrate pests relating to combinations comprising (a) 3-bromo-N-[4-chloro-2-methyl-6-[(methylamino)carbonyl]phenyl]-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide, and its N-oxides, and suitable salts thereof
-
Citations
25 Claims
-
1. A mixture comprising:
-
(a) a compound of Formula 1, 3-bromo-N-[4-chloro-2-methyl-6-[(methylamino)carbonyl]phenyl]-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide, an N-oxide, or a salt thereof, and a component (b) wherein the component (b) is at least one invertebrate pest control agent selected from the group consisting of (b1) neonicotinoids;
(b2) cholinesterase inhibitors;
(b3) sodium channel modulators;
(b4) chitin synthesis inhibitors;
(b5) ecdysone agonists;
(b6) lipid biosynthesis inhibitors;
(b7) macrocyclic lactones;
(b8) GABA-regulated chloride channel blockers;
(b9) juvenile hormone mimics;
(b10) ryanodine receptor ligands;
(b11) octopamine receptor ligands;
(b12) mitochondrial electron transport inhibitors;
(b13) nereistoxin analogs;
(b14) pyridalyl;
(b15) flonicamid;
(b16) pymetrozine;
(b17) dieldrin;
(b18) metaflumizone;
(b19) biological agents; and
salts of compounds of (b1) through (b18). - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)
-
Specification